Small Cell Lung Cancer Progression and Recurrence

Facing SCLC relapse? Learn about second-line treatment options for 2026, including platinum rechallenge, lurbinectedin, tarlatamab, and clinical trials.

When you have small cell lung cancer (SCLC), your cancer care team may talk with you about the risk of cancer spreading to your brain. For many years, doctors have used a treatment called prophylactic cranial irradiation (PCI) to lower that risk. PCI is radiation given to the brain even when scans don’t show cancer […]

Facing small cell lung cancer recurrence? Learn how the timing of your relapse influences second-line treatment options, including Lurbinectedin and clinical trials.

A small cell lung cancer (SCLC) diagnosis reshapes everything: your priorities, your routines, and your sense of what comes next. For many patients, particularly those navigating extensive-stage disease, the emotional weight of that reality is enormous. Depression isn’t simply an understandable response to hard news. Emerging research shows it’s a biological variable that can measurably […]

It’s common for small cell lung cancer (SCLC) to come back after initial treatment. Massachusetts General Hospital Dr. Catherine Meador shares with us, “We expect at some point the cancer will return and grow back. The question is when and how much?” If that happens, know that you have options. We asked lung cancer experts […]

For people diagnosed with small cell lung cancer (SCLC), the risk of recurrence is a real concern. Relapsed SCLC is common, but understanding how SCLC behaves, how it’s monitored, and what treatment options are emerging can help you feel more informed and prepared. How soon can SCLC come back? Dr. Charles Rudin of Memorial Sloan […]

In this final “Ask the Webinar” recap,  Dr. Charles Rudin, a leading lung cancer specialist and Deputy Director of the Cancer Center at Memorial Sloan Kettering Cancer Center, answered patient questions on recurrence, clinical trials, and new therapies for small cell lung cancer (SCLC).  Whether you’re navigating treatment decisions or trying to balance quality of […]